Plasma phospholipids profiling changes were associated with the therapeutic response to Roxadustat in peritoneal dialysis patients

Plasma phospholipids profiling changes were associated with the therapeutic response to Roxadustat in peritoneal dialysis patients

Background: Elevated Phospholipids (PLs) and sphingolipid (SM) metabolism relates to with poor clinical status and adverse outcome of end-stage kidney disease patients undergoing peritoneal dialysis (PD). Studies have suggested that the use of hypoxia-inducible factor prolyl hydroxylase inhibitor (H...

Full description

Bibliographic Details
Main Authors: Ya-Hui Yang, Yishakejiang Saimaiti, Yang Zhao, Wen Tang
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-12-01
Series:Frontiers in Physiology
Subjects:
peritoneal dialysis
phospholipids
hypoxia inducible factor prolyl hydroxylase inhibitors
anemia
end-stage kidney disease
Online Access:https://www.frontiersin.org/articles/10.3389/fphys.2023.1279578/full

Internet

https://www.frontiersin.org/articles/10.3389/fphys.2023.1279578/full

Similar Items